Enovis Corporation (ENOV)
- Previous Close
38.77 - Open
38.52 - Bid 38.54 x 800
- Ask 38.56 x 4000
- Day's Range
38.39 - 38.93 - 52 Week Range
38.27 - 65.03 - Volume
483,849 - Avg. Volume
653,843 - Market Cap (intraday)
2.164B - Beta (5Y Monthly) 2.01
- PE Ratio (TTM)
-- - EPS (TTM)
-1.95 - Earnings Date Nov 6, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
68.00
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.
www.enovis.com6,550
Full Time Employees
December 31
Fiscal Year Ends
Sector
Specialty Industrial Machinery
Industry
Recent News: ENOV
View MorePerformance Overview: ENOV
Trailing total returns as of 10/10/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ENOV
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ENOV
View MoreValuation Measures
Market Cap
2.17B
Enterprise Value
3.55B
Trailing P/E
--
Forward P/E
12.76
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.11
Price/Book (mrq)
0.66
Enterprise Value/Revenue
1.85
Enterprise Value/EBITDA
20.41
Financial Highlights
Profitability and Income Statement
Profit Margin
-4.73%
Return on Assets (ttm)
-0.10%
Return on Equity (ttm)
-3.16%
Revenue (ttm)
1.91B
Net Income Avi to Common (ttm)
-107.11M
Diluted EPS (ttm)
-1.95
Balance Sheet and Cash Flow
Total Cash (mrq)
35M
Total Debt/Equity (mrq)
43.09%
Levered Free Cash Flow (ttm)
-26.55M
Research Analysis: ENOV
View MoreCompany Insights: ENOV
ENOV does not have Company Insights
Research Reports: ENOV
View MoreLowering target price to $34.00
ENOVIS CORP has an Investment Rating of SELL; a target price of $34.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.
RatingPrice TargetLowering target price to $35.00
ENOVIS CORP has an Investment Rating of SELL; a target price of $35.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
RatingPrice TargetRaising target price to $36.00
ENOVIS CORP has an Investment Rating of SELL; a target price of $36.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
RatingPrice TargetLowering target price to $35.00
ENOVIS CORP has an Investment Rating of SELL; a target price of $35.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
RatingPrice Target